歐盟MDR2017525日發布後,緩衝期三年後即2020526日執行,表示廠商明年5月後只能遵守MDR要求,廠商第一步應開始評估產品在MDR要求下是符合哪一個分類分級,而原先MDDClassification Rules18個到了MDR則變成了22個,擴增了4個,包括使用奈米材料的醫材、純軟體醫材等,分類分級如列表,確認了產品等級後才能進一步確認MDR申請符合的路徑。

 

 

Non Invasive Devices

Classification

Rule 1

Devices that either do not touch patient or contact only intact skin

I

Rule 2

Channelling or storing blood, body liquids, cells or tissues, liquids or gases for the purpose of eventual infusion, administration or introduction into the body

  • If they may be connected to a class IIa, class IIb or class III active device

IIa

  • If they are intended for use for channelling or storing blood or other body liquids or for storing organs, parts of organs or body cells and tissues

IIa

The devices are intended for use for blood bags.

IIb

In all other cases

I

Rule 3

Modifying the biological or chemical composition of human tissues or cells, blood, other body liquids or other liquids intended for implantation or administration into the body

IIb

  • Unless the treatment for which the device is used consists of filtration, centrifugation or exchanges of gas, heat

IIa

The devices consisting of a substance or a mixture of substances intended to be used in vitro in direct contact with human cells, tissues or organs taken from the human body or used in vitro with human embryos before their implantation or administration into the body

III

Rule 4

In contact with injured skin or mucous membrane

  • If they are intended to be used as a mechanical barrier, for compression or for absorption of exudates

I

  • If they are intended to be used principally for injuries to skin which have breached the dermis or mucous membrane and can only heal by secondary intent

IIb

  • If they are principally intended to manage the micro-environment of injured skin or mucous membrane

IIa

  • In all other cases

IIa

This rule applies also to the invasive devices that come into contact with injured mucous membrane.

 

Invasive Devices

Classification

Rule 5

Invasive in body orifice or stoma (Not Surgically)

All invasive devices with respect to body orifices, other than surgically invasive devices, which are not intended for connection to an active device or which are intended for connection to a class I active device

I

  • If they are intended for transient use

I

  • If they are intended for short-term use

IIa

  • Except if they are used in the oral cavity as far as the pharynx, in an ear canal up to the ear drum or in the nasal cavity

I

  • If they are intended for long-term use

IIb

  • Except if they are used in the oral cavity as far as the pharynx, in an ear canal up to the ear drum or in the nasal cavity and are not liable to be absorbed by the mucous membrane

IIa

All invasive devices with respect to body orifices, other than surgically invasive devices, intended for connection to a class IIa, class IIb or class III active device

IIa

Rule 6

Surgically invasive devices for transient use (< 60 minutes)

All surgically invasive devices intended for transient use

IIa

  • Unless they are intended specifically to control, diagnose, monitor or correct a defect of the heart or of the central circulatory system through direct contact with those parts of the body

III

  • Unless they are reusable surgical instruments

I

  • Unless they are intended specifically for use in direct contact with the heart or central circulatory system or the central nervous system

III

  • Unless they are intended to supply energy in the form of ionising radiation

IIb

  • Unless they have a biological effect or are wholly or mainly absorbed

IIb

  • Unless they are intended to administer medicinal products by means of a delivery system, if such administration of a medicinal product is done in a manner that is potentially hazardous taking account of the mode of application

IIb

Rule 7

Surgically invasive devices for short-term use (>60 minutes, <30 days)

All surgically invasive devices intended for short-term use

IIa

  • Unless they are intended specifically to control, diagnose, monitor or correct a defect of the heart or of the central circulatory system through direct contact with those parts of the body

III

  • Unless they are intended specifically for use in direct contact with the heart or central circulatory system or the central nervous system

III

  • Unless they are intended to supply energy in the form of ionizing radiation

IIb

  • Unless they have a biological effect or are wholly or mainly absorbed

III

  • Unless they are intended to undergo chemical change in the body, except if the devices are placed in the teeth; or are intended to administer medicines

IIb

Rule 8

Implantable devices and long-term surgically invasive devices (> 30 days)

All implantable devices and long-term surgically invasive devices

IIb

  • Unless they are intended to be placed in the teeth

IIa

  • Unless they are intended to be used in direct contact with the heart, the central circulatory system or the central nervous system

III

  • Unless they have a biological effect or are wholly or mainly absorbed

III

  • Unless they are intended to undergo chemical change in the body, except if the devices are placed in the teeth

III

  • Unless they are intended to administer medicinal products

III

  • Unless they are active implantable devices or their accessories

III

  • Unless they are breast implants or surgical meshes

III

  • Unless they are total or partial joint replacements, with the exception of ancillary components such as screws, wedges, plates and instruments

III

  • Unless they are spinal disc replacement implants or are implantable devices that come into contact with the spinal column, with the exception of components such as screws, wedges, plates and instruments

III

 

Active Devices

Classification

Rule 9

All active therapeutic devices intended to administer or exchange energy

IIa

  • Unless their characteristics are such that they may administer energy to or exchange energy with the human body in a potentially hazardous way, taking account of the nature, the density and site of application of the energy

IIb

All active devices intended to control or monitor the performance of active therapeutic class IIb devices, or intended directly to influence the performance of such devices

IIb

All active devices intended to emit ionizing radiation for therapeutic purposes, including devices which control or monitor such devices, or which directly influence their performance

IIb

All active devices that are intended for controlling, monitoring or directly influencing the performance of active implantable devices

III

Rule 10

Active devices intended for diagnosis and monitoring

  • If they are intended to supply energy which will be absorbed by the human body
  • If they are intended to image in vivo distribution of radiopharmaceuticals
  • If they are intended to allow direct diagnosis or monitoring of vital physiological processes

IIa

Active devices intended to illuminate the patient's body, in the visible spectrum

I

Active devices are specifically intended for monitoring of vital physiological parameters and the nature of variations of those parameters is such that it could result in immediate danger to the patient, for instance variations in cardiac performance, respiration, activity of the central nervous system, or they are intended for diagnosis in clinical situations where the patient is in immediate danger

IIb

Active devices intended to emit ionizing radiation and intended for diagnostic or therapeutic radiology, including interventional radiology devices and devices which control or monitor such devices, or which directly influence their performance

IIb

Rule 11 (NEW)

Software intended to provide information which is used to take decisions with diagnosis or therapeutic purposes

IIa

  • Except if such decisions have an impact that may cause death or an irreversible deterioration of a person's state of health

III

  • Except if such decisions have an impact that may cause a serious deterioration of a person's state of health or a surgical intervention

IIb

Software intended to monitor physiological processes

IIa

  • Expect if it is intended for monitoring of vital physiological parameters, where the nature of variations of those parameters is such that it could result in immediate danger to the patient

IIb

All other software

I

Rule 12

All active devices intended to administer and/or remove medicinal products, body liquids or other substances to or from the body

IIa

  • Unless this is done in a manner that is potentially hazardous, taking account of the nature of the substances involved, of the part of the body concerned and of the mode of application

IIb

Rule 13

All other active devices

I

 

Special Rules

Classification

Rule 14

All devices incorporating, as an integral part, a substance which, if used separately, can be considered to be a medicinal product, as defined in point 2 of Article 1 of Directive 2001/83/EC, including a medicinal product derived from human blood or human plasma, as defined in point 10 of Article 1 of that Directive, and that has an action ancillary to that of the devices

III

Rule 15

All devices used for contraception or prevention of the transmission of sexually transmitted diseases

IIb

  • Unless they are implantable or long term invasive devices

III

Rule 16

All devices intended specifically to be used for disinfecting, cleaning, rinsing or, where appropriate, hydrating contact lenses

IIb

All devices intended specifically to be used for disinfecting or sterilising medical devices

IIa

  • Unless they are disinfecting solutions or washer-disinfectors intended specifically to be used for disinfecting invasive devices, as the end point of processing

IIb

This rule does not apply to devices that are intended to clean devices other than contact lenses by means of physical action only.

Rule 17

Devices specifically intended for recording of diagnostic images generated by X-ray radiation

IIa

Rule 18

All devices manufactured utilising tissues or cells of human or animal origin, or their derivatives, which are non- viable or rendered non-viable, unless such devices are manufactured utilising tissues or cells of animal origin, or their derivatives, which are non-viable or rendered non-viable and are devices intended to come into contact with intact skin only

III

Rule 19 (New)

All devices incorporating or consisting of nanomaterial

  • If they present a high or medium potential for internal exposure

III

  • If they present a low potential for internal exposure

IIb

  • If they present a negligible potential for internal exposure

IIa

Rule 20 (New)

All invasive devices with respect to body orifices, other than surgically invasive devices, which are intended to administer medicinal products by inhalation

IIa

  • Unless their mode of action has an essential impact on the efficacy and safety of the administered medicinal product or they are intended to treat life- threatening conditions

IIb

Rule 21 (New)

Devices that are composed of substances or of combinations of substances that are intended to be introduced into the human body via a body orifice or applied to the skin and that are absorbed by or locally dispersed in the human body

  • If they, or their products of metabolism, are systemically absorbed by the human body in order to achieve the intended purpose

III

  • If they achieve their intended purpose in the stomach or lower gastrointestinal tract and they, or their products of metabolism, are systemically absorbed by the human body

III

  • If they are applied to the skin or if they are applied in the nasal or oral cavity as far as the pharynx, and achieve their intended purpose on those cavities

IIa

  • All other cases

IIb

Rule 22 (New)

Active therapeutic devices with an integrated or incorporated diagnostic function which significantly determines the patient management by the device, such as closed loop systems or automated external defibrillators

III

 

 

arrow
arrow

    M.D. 發表在 痞客邦 留言(1) 人氣()